Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: China Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20062
20072
20083
20121
20141
20161
20181
20211
20223
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status3
Recruiting2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Boehringer Ingelheim2
Bristol-Myers Squibb2
Sanofi2
Anthos Therapeutics, Inc.1
AstraZeneca1
Beijing Anzhen Hospital1
Biosense Webster, Inc.1
China National Center for Cardiovascular Diseases1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation19
Stroke5
Atrial Flutter2
Embolism2
Arrhythmias, Cardiac1
Heart Failure1
Hyperkalemia1
Ischemic Attack, Transient1
Rheumatic Heart Disease1
Tachycardia, Ventricular1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.